Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
New drug combination offers hope to women with rare treatment-resistant ovarian cancer
A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ovarian cancer that rarely responds to chemotherapy or hormone therapy.
Higher doses of radiotherapy cuts treatment time by 75% in localised prostate cancer patients, while maintaining high cure rates
People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, according to researchers from The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust.
Prostate cancer spit test could save the NHS £500 million a year
Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, thanks to a new spit test which can be taken at home.
Personalised radiotherapy for people with bladder cancer shows promise
Researchers are a step closer to revolutionising how doctors use radiotherapy to treat patients with muscle-invasive bladder cancer.
New genetic testing pathways could ensure patients get personalised treatments and help to catch more BRCA-linked cancer cases
Scientists have developed a new clinical pathway for testing for the cancer-causing faults in the BRCA gene that could ensure patients get the right treatment and boost the number of people who get tested.
Large-scale study confirms well-established cancer risk factors and identifies new ones
Researchers have examined thousands of genetically defined traits to identify possible causal relationships for eight common cancers.
New biological findings open the door to improved outcomes for young adults with sarcoma
A new study has answered the long-standing question of why improvements in survival outcomes for young people with cancerous soft tissue tumours have lagged behind those for their paediatric and older adult counterparts.
Breast and ovarian cancer linked to thousands of new gene variants
New research identifies specific genetic changes that can increase someone's risk of breast and ovarian cancers, to help guide clinical decision-making
ESMO 2024: More than half of advanced melanoma patients treated with combination immunotherapy survive the disease for at least 10 years
More than half of people diagnosed with advanced melanoma are now surviving the disease for ten years or more when they receive a combination immunotherapy treatment, according to a study led by researchers from the ICR and The Royal Marsden.
ESMO 2024: Routine MRI scans detect cancers in asymptomatic patients with rare genetic condition
A study has found that people with Li-Fraumeni syndrome would benefit from yearly whole-body MRI scans to screen for cancers.
Improved breast cancer risk tools on the horizon as major study reaches 20-year halfway point
Scientists are developing breast cancer risk tools that will help to identify women at high risk, even if they do not have a family history of the disease, thanks to one of the world’s largest and longest-running studies into the causes of breast cancer.
New method could lower radiotherapy doses for some cancer patients
A special type of MRI scan where patients inhale 100% oxygen could result in lower radiotherapy doses for some cancer patients.